Could DePuy Executive’s Promotion Hurt Company?
The New York Times suggests that new details revealed at a trial in Los Angeles this week could hurt Johnson & Johnson’s ability to move forward from the controversy surrounding the ASR XL hip implants. The executive who oversaw the … LEARN MORE